FDA approves fremanezumab-vfrm for migraine prevention in children aged 6 years, older
The indication approved is for children aged 6 years and older who weigh at least 45 kg (99 lbs) for the preventive treatment of episodic migraine.
Managing mental health between specialist visits with Elizabeth Reichert, PhD
Psychologist Elizabeth Reichert, PhD, encourages primary care providers to use validation and connection to support mental health during routine visits.
Study: Intensive nurse home services did not reduce adverse outcome likelihood
Though intensive nurse home services did not change outcomes in this South Carolina study, authors noted more research is needed on a larger scale to determine influence on adverse outcomes.
Q&A: A deep dive into influenza-associated acute necrotizing encephalopathy
The authors of a recent study on flu-linked necrotizing encephalopathy in children give a deep dive into their findings and the biggest takeaways from the study.
Experts discuss importance of vaccination prior to school year
As families prepare for a new school year, pediatricians are essential in helping parents navigate immunization schedules and school requirements and ensuring vaccine confidence.
Flu-linked necrotizing encephalopathy in children carries high risks
A US study finds influenza-associated necrotizing encephalopathy in children has high mortality and disability, underscoring need for early care.
Aligning vaccinations with the start of a new school year
Puzzler poll: Can you identify this bite?
Despite their frequency, it can be challenging to distinguish between types of bites. Can you identify the source of this bite mark?
Media and mental health, hemophilia approval, July FDA recap, and more
Get caught up with Contemporary Pediatrics! This list helps you navigate our top stories from the week, all in one place.
CDC: Kindergarten vaccination decreases, exemptions increase
New CDC data show fewer kindergartners are fully vaccinated as exemption rates increased during the 2024-2025 school year.
FDA news in pediatrics: July 2025
A look back at the FDA submissions and regulatory decisions in the pediatric health care space from July 2025.
Top 5 pediatric health headlines you missed in July 2025
Take a quick look at everything you may have missed last month, including the top FDA approvals and latest clinical updates.
FDA approves concizumab-mtci for hemophilia A/B without inhibitors in patients 12 years and older
The FDA approved concizumab-mtci (Alhemo; Novo Nordisk) for hemophilia A/B without inhibitors, offering once-daily subcutaneous prophylaxis that significantly reduces bleeding rates.
Elizabeth Reichert, PhD, talks media exposure and mental health
Elizabeth Reichert, PhD, shares practical tips for pediatricians to help families monitor teen media use and recognize early signs of anxiety.
ACIP changes prompt concern as pediatricians prepare for fall vaccine season
Pediatricians are urged to follow 2024 guidelines amid ACIP upheaval, vaccine hesitancy, and access issues as children head back to school.
Richard Auchus, MD: Crinecerfont's positive weight-related outcomes in children with CAH
Richard Auchus, MD, PhD, highlights data showing that crinecerfont use in children with CAH can improve metabolic outcomes.
Larazotide safe, could improve MISC symptoms as adjuvant therapy
“While our study is small, its results are powerful and have implications not only for MIS-C, but potentially for long COVID,” said lead author Lael Yonker, MD.
Study: Potty training challenges common, with anxiety and setbacks affecting many families
Many families face common potty training challenges, including anxiety and setbacks, highlighting the need for patience and personalized strategies.
Alopecia areata data: Upadacitinib demonstrates improvements in scalp hair coverage
Achieving the primary endpoint, 44.6% and 54.3% of patients treated with upadacitinib (15 mg and 30 mg) reached 80% or more scalp hair coverage.
FDA grants fast track designation to rezpegaldesleukin for severe alopecia areata in patients 12 years and older
Nektar Therapeutics remains on track to announce top-line phase 2 data in December.
FDA approves pegcetacoplan as first treatment for C3 glomerulopathy or IC-MPGN
Pegcetacoplan (Empaveli; Apellis Pharmaceuticals) is indicated for patients 12 years or older to reduce proteinuria.
WATCH: Experts react to the FDA approval of sepiapterin to treat PKU
Suzanne Hollander, MS, RD, LDN; and Timothy Tramontana, MD, offer thoughts on newly FDA-approved sepiapterin for PKU.
FDA approves sepiapterin to treat phenylketonuria in adult, pediatric patients
“Without treatment, individuals with PKU would have very high blood Phe levels...so that results in neurocognitive deficits and mood disorders," Suzanne Hollander, MS, RD, LDN, said.
FDA approves avatrombopag for pediatric immune thrombocytopenia, including new sprinkle formulation
The FDA has approved avatrombopag and new sprinkle formulation for children ≥1 year with chronic ITP, offering an oral, food-flexible treatment option.
Study: Daily emollient for infants could reduce atopic dermatitis incidence
The study enrolled infants not selected for risk, a population that has been studied few times with regard to emollient intervention.
AAP recommends all healthy children 6 months or older receive influenza vaccine
Of the 253 influenza-related pediatric deaths through June 21, 2025, 42.7% occurred in children without a high-risk medical condition.
New case study, HHS adopts influenza recommendation, and back-to-school vaccination
Atopic dermatitis phenotypes and allergic disease development in children
Study links early childhood eczema timing to risk of allergies like food allergy, asthma, and rhinitis, with five distinct disease phenotypes identified.
Lori Handy, MD: Vaccine-only visits can help ease back-to-school gaps
Lori Handy, MD, MSCE, highlights how pediatricians can better prepare families and systems for missed vaccines during the back-to-school rush.
Tyra Bryant-Stephens, MD, talks asthma reminders ahead of school year
Tyra Bryant-Stephens, MD, encourages families to revisit asthma triggers, refill medications, and manage allergies to prevent avoidable complications.
